loading page

Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A Case report
  • +1
  • Morten Bahrt Haulrig,
  • Signe Nielsen,
  • Jesper Elberling,
  • Lone Skov
Morten Bahrt Haulrig
Gentofte Hospital Dermatologisk Afdelin

Corresponding Author:[email protected]

Author Profile
Signe Nielsen
Herlev Hospital, University of Copenhagen
Author Profile
Jesper Elberling
Gentofte Hospital Dermatologisk Afdelin
Author Profile
Lone Skov
Gentofte Hospital
Author Profile


Linear IgA/IgG bullous dermatosis (LAGBD) is a rare, autoimmune blistering skin disease. We report a case of LAGBD in a 70-year-old woman. All common treatments were discontinued due to side effects or lack of treatment response. The patient was successfully treated with omalizumab which cleared her lesions after three months.
03 Sep 2021Submitted to Clinical Case Reports
07 Sep 2021Submission Checks Completed
07 Sep 2021Assigned to Editor
24 Sep 2021Reviewer(s) Assigned
16 Oct 2021Review(s) Completed, Editorial Evaluation Pending
22 Oct 2021Editorial Decision: Revise Minor
10 Dec 20211st Revision Received
13 Jan 2022Submission Checks Completed
13 Jan 2022Assigned to Editor
13 Jan 2022Review(s) Completed, Editorial Evaluation Pending
19 Jan 2022Editorial Decision: Accept
Mar 2022Published in Clinical Case Reports volume 10 issue 3. 10.1002/ccr3.5368